First human test for new obesity injection begins
NCT ID NCT06842186
Summary
This is a first-in-human study to test the safety and effects of an experimental drug called WVE-007 in adults with overweight or obesity. The drug is given as an injection under the skin. The main goal is to see how well the body tolerates it and how it behaves in the bloodstream.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY AND OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ARENSIA Research Clinic
RECRUITINGChisinau, MD-2025, Moldova
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Arensia Clinics S.R.L.
RECRUITINGBucharest, 011658, Romania
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Parexel International Early Phase Clinical Unit
RECRUITINGHarrow, HA1 3UJ, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Parexel International-EPCU Baltimore
RECRUITINGBaltimore, Maryland, 21225, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Simbec-Orion Clinical Pharmacology
RECRUITINGMerthyr Tydfil, CF48 4DR, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Spitalul Clinic Judetean De Urgenta Cluj
RECRUITINGCluj-Napoca, 400006, Romania
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.